News stories about Dextera Surgical (NASDAQ:DXTR) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Dextera Surgical earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 45.7495510821804 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the news stories that may have impacted Accern Sentiment’s rankings:

Shares of Dextera Surgical (NASDAQ:DXTR) traded up $0.01 during mid-day trading on Tuesday, reaching $0.22. The company’s stock had a trading volume of 4,307,547 shares, compared to its average volume of 6,040,000. Dextera Surgical has a one year low of $0.11 and a one year high of $2.33. The company has a debt-to-equity ratio of -0.41, a quick ratio of 0.59 and a current ratio of 0.71.

Dextera Surgical (NASDAQ:DXTR) last announced its quarterly earnings data on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.29). The firm had revenue of $1.05 million for the quarter, compared to analyst estimates of $1.03 million. sell-side analysts anticipate that Dextera Surgical will post -0.25 earnings per share for the current fiscal year.

DXTR has been the topic of several analyst reports. Ladenburg Thalmann Financial Services initiated coverage on Dextera Surgical in a report on Wednesday, August 16th. They set a “buy” rating and a $0.80 price target on the stock. Zacks Investment Research upgraded Dextera Surgical from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 10th. Finally, Wedbush lowered their price target on Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating on the stock in a report on Wednesday, July 12th.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Dextera Surgical (DXTR) Stock Price” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.dailypolitical.com/2017/11/07/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-dextera-surgical-dxtr-stock-price.html.

About Dextera Surgical

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Insider Buying and Selling by Quarter for Dextera Surgical (NASDAQ:DXTR)

Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.